Epithelial alarmins at the crossroads of type 2 immunity: Experimental insights from skin and airway models.
文献摘要
Epithelial alarmins such as thymic stromal lymphopoietin (TSLP), interleukin-33 (IL-33) and IL-25 orchestrate the initiation of type 2 immune responses at barrier surfaces. Dysregulated release of these cytokines links environmental cues to chronic allergic inflammation in the skin and airways. Recent experimental work using human keratinocytes, organotypic 3D skin equivalents, airway epithelial models, and murine challenge systems shows that barrier disruption, allergens, microbial components, and environmental irritants or pollutants induce strong alarmin expression. These mediators condition dendritic cells (DCs) and group 2 innate lymphoid cells (ILC2s), generating the cytokine milieu that drives Th2 polarization and neuro-immune crosstalk. This mini review summarizes molecular principles, highlights recent mechanistic findings from experimental systems, and discusses translational implications for allergic diseases such as atopic dermatitis, asthma, and chronic rhinosinusitis with nasal polyps (CRSwNP). Understanding the epithelial-alarmin axis offers opportunities for targeted prevention and therapy across barrier organs.